Terms: = Colorectal cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967 AND Treatment
6 results:
1. Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).
Arora SP; Tenner L; Sarantopoulos J; Morris J; Liu Q; Mendez JA; Curiel T; Michalek J; Mahalingam D
Br J Cancer; 2022 Oct; 127(6):1153-1161. PubMed ID: 35739299
[TBL] [Abstract] [Full Text] [Related]
2. Hospital volume and mortality in liver resections for colorectal metastasis using population-based administrative data.
Hunger R; Mantke A; Herrmann C; Grimm AL; Ludwig J; Mantke R
J Hepatobiliary Pancreat Sci; 2019 Dec; 26(12):548-556. PubMed ID: 31562836
[TBL] [Abstract] [Full Text] [Related]
3. Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
Bahrami A; Hassanian SM; ShahidSales S; Farjami Z; Hasanzadeh M; Anvari K; Aledavood A; Maftouh M; Ferns GA; Khazaei M; Avan A
J Cell Physiol; 2018 Mar; 233(3):2058-2066. PubMed ID: 28262927
[TBL] [Abstract] [Full Text] [Related]
4. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract] [Full Text] [Related]
5. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract] [Full Text] [Related]
6. Activation and involvement of Ral GTPases in colorectal cancer.
Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
[TBL] [Abstract] [Full Text] [Related]
